Journal of Clinical Epidemiology
Volume 63, Issue 10 , Pages 1053-1058, October 2010

Real-world effectiveness of new medicines should be evaluated by appropriately designed clinical trials

  • Nick Freemantle

      Affiliations

    • School of Health and Population Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-121-414-7943; fax: +44-121-414-3353.
    • ,
  • Thomas Strack

      Affiliations

    • Takeda Pharmaceuticals, Global Research and Development Center, Deerfield, IL, USA

Accepted 28 July 2009. published online 02 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0895-4356(09)00226-1

doi:10.1016/j.jclinepi.2009.07.013

Journal of Clinical Epidemiology
Volume 63, Issue 10 , Pages 1053-1058, October 2010

Article Tools